Cargando…
Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies
Background: Transcatheter pulmonary valve implantation (TPVI) is an effective non-surgical treatment method for patients with right ventricle outflow tract dysfunction. The Medtronic Melody and the Edwards Sapien are the two valves approved for use in TPVI. Since TPVI patients are typically younger,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419461/ https://www.ncbi.nlm.nih.gov/pubmed/37568289 http://dx.doi.org/10.3390/jcm12154886 |
_version_ | 1785088523423973376 |
---|---|
author | Machanahalli Balakrishna, Akshay Dilsaver, Danielle B. Aboeata, Ahmed Gowda, Ramesh M. Goldsweig, Andrew M. Vallabhajosyula, Saraschandra Anderson, Jason H. Simard, Trevor Jhand, Aravdeep |
author_facet | Machanahalli Balakrishna, Akshay Dilsaver, Danielle B. Aboeata, Ahmed Gowda, Ramesh M. Goldsweig, Andrew M. Vallabhajosyula, Saraschandra Anderson, Jason H. Simard, Trevor Jhand, Aravdeep |
author_sort | Machanahalli Balakrishna, Akshay |
collection | PubMed |
description | Background: Transcatheter pulmonary valve implantation (TPVI) is an effective non-surgical treatment method for patients with right ventricle outflow tract dysfunction. The Medtronic Melody and the Edwards Sapien are the two valves approved for use in TPVI. Since TPVI patients are typically younger, even a modest annual incidence of infective endocarditis (IE) is significant. Several previous studies have shown a growing risk of IE after TPVI. There is uncertainty regarding the overall incidence of IE and differences in the risk of IE between the valves. Methods: A systematic search was conducted in the MEDLINE, EMBASE, PubMed, and Cochrane databases from inception to 1 January 2023 using the search terms ‘pulmonary valve implantation’, ‘TPVI’, or ‘PPVI’. The primary outcome was the pooled incidence of IE following TPVI in Melody and Sapien valves and the difference in incidence between Sapien and Melody valves. Fixed effect and random effect models were used depending on the valve. Meta-regression with random effects was conducted to test the difference in the incidence of IE between the two valves. Results: A total of 22 studies (including 10 Melody valve studies, 8 Sapien valve studies, and 4 studies that included both valves (572 patients that used the Sapien valve and 1395 patients that used the Melody valve)) were used for the final analysis. Zero IE incidence following TPVI was reported by eight studies (66.7%) that utilized Sapien valves compared to two studies (14.3%) that utilized Melody valves. The pooled incidence of IE following TPVI with Sapien valves was 2.1% (95% CI: 0.9% to 5.13%) compared to 8.5% (95% CI: 4.8% to 15.2%) following TPVI with Melody valves. Results of meta-regression indicated that the Sapien valve had a 79.6% (95% CI: 24.2% to 94.4%, p = 0.019; R(2) = 34.4) lower risk of IE incidence compared to the Melody valve. Conclusions: The risk of IE following TPVI differs significantly. A prudent valve choice in favor of Sapien valves to lower the risk of post-TPVI endocarditis may be beneficial. |
format | Online Article Text |
id | pubmed-10419461 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104194612023-08-12 Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies Machanahalli Balakrishna, Akshay Dilsaver, Danielle B. Aboeata, Ahmed Gowda, Ramesh M. Goldsweig, Andrew M. Vallabhajosyula, Saraschandra Anderson, Jason H. Simard, Trevor Jhand, Aravdeep J Clin Med Article Background: Transcatheter pulmonary valve implantation (TPVI) is an effective non-surgical treatment method for patients with right ventricle outflow tract dysfunction. The Medtronic Melody and the Edwards Sapien are the two valves approved for use in TPVI. Since TPVI patients are typically younger, even a modest annual incidence of infective endocarditis (IE) is significant. Several previous studies have shown a growing risk of IE after TPVI. There is uncertainty regarding the overall incidence of IE and differences in the risk of IE between the valves. Methods: A systematic search was conducted in the MEDLINE, EMBASE, PubMed, and Cochrane databases from inception to 1 January 2023 using the search terms ‘pulmonary valve implantation’, ‘TPVI’, or ‘PPVI’. The primary outcome was the pooled incidence of IE following TPVI in Melody and Sapien valves and the difference in incidence between Sapien and Melody valves. Fixed effect and random effect models were used depending on the valve. Meta-regression with random effects was conducted to test the difference in the incidence of IE between the two valves. Results: A total of 22 studies (including 10 Melody valve studies, 8 Sapien valve studies, and 4 studies that included both valves (572 patients that used the Sapien valve and 1395 patients that used the Melody valve)) were used for the final analysis. Zero IE incidence following TPVI was reported by eight studies (66.7%) that utilized Sapien valves compared to two studies (14.3%) that utilized Melody valves. The pooled incidence of IE following TPVI with Sapien valves was 2.1% (95% CI: 0.9% to 5.13%) compared to 8.5% (95% CI: 4.8% to 15.2%) following TPVI with Melody valves. Results of meta-regression indicated that the Sapien valve had a 79.6% (95% CI: 24.2% to 94.4%, p = 0.019; R(2) = 34.4) lower risk of IE incidence compared to the Melody valve. Conclusions: The risk of IE following TPVI differs significantly. A prudent valve choice in favor of Sapien valves to lower the risk of post-TPVI endocarditis may be beneficial. MDPI 2023-07-25 /pmc/articles/PMC10419461/ /pubmed/37568289 http://dx.doi.org/10.3390/jcm12154886 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Machanahalli Balakrishna, Akshay Dilsaver, Danielle B. Aboeata, Ahmed Gowda, Ramesh M. Goldsweig, Andrew M. Vallabhajosyula, Saraschandra Anderson, Jason H. Simard, Trevor Jhand, Aravdeep Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title | Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title_full | Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title_fullStr | Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title_full_unstemmed | Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title_short | Infective Endocarditis Risk with Melody versus Sapien Valves Following Transcatheter Pulmonary Valve Implantation: A Systematic Review and Meta-Analysis of Prospective Cohort Studies |
title_sort | infective endocarditis risk with melody versus sapien valves following transcatheter pulmonary valve implantation: a systematic review and meta-analysis of prospective cohort studies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419461/ https://www.ncbi.nlm.nih.gov/pubmed/37568289 http://dx.doi.org/10.3390/jcm12154886 |
work_keys_str_mv | AT machanahallibalakrishnaakshay infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT dilsaverdanielleb infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT aboeataahmed infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT gowdarameshm infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT goldsweigandrewm infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT vallabhajosyulasaraschandra infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT andersonjasonh infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT simardtrevor infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies AT jhandaravdeep infectiveendocarditisriskwithmelodyversussapienvalvesfollowingtranscatheterpulmonaryvalveimplantationasystematicreviewandmetaanalysisofprospectivecohortstudies |